Posted on 26/09/202426/09/2024 by Pencis Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award IQVIA | NetherlandsĀ Author Profile Scopus šMrs. Anke van Engen š¼ Managing Principal, IQVIA Payer Evidence Solutions Amsterdam, the Netherlands š¬Profile: Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success. šØāāļøKey Specialties: šGeneral management šStrategic planning & business development š©ŗHealth economics & outcomes research (HEOR) š„Market access strategy (MA) & execution šHealth technology assessment (HTA) šClient relationship management & coaching š¼Professional Experience: š2023 ā Present: Managing Principal, IQVIA Value & Payer Evidence Co-leads EMEA Real World Evidence Leadership Team Oversees integrated evidence & EU HTA offerings š”2020 ā 2023: Senior Principal, IQVIA Real World Solutions Led the development of EMEA payer evidence solutions Drove go-to-market strategy and key client partnerships š2017 ā 2020: Senior Principal, IQVIA Consulting Services Managed partnerships with large pharmaceutical clients Led the HTA Accelerator solution for launch readiness š2014 ā 2017: Principal, Quintiles Advisory Services Led development of the flagship HTA Accelerator platform Senior oversight on HEOR/MA strategy and projects šEducation: š§ŖMSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands šBusiness leadership programs at IMD, Lausanne, Switzerland šProfessional Affiliations: š§¬Active member of ISPOR and HTAi š”IQVIA representative at GetReal Institute š Awards & Honors: š2023: Issue panel ranked #1 at ISPOR Europe š¦2014: Won Sharktank contest for HTA Accelerator innovation šMultiple ISPOR awards for best podium and poster presentations š Conclusion š¼In conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. š šš¬NOTABLE PUBLICATION: The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment Authors: van Engen A, KrĆ¼ger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D Journal: Value Health Year: 2024 Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J Journal: Value Health Year: 2021 Call in the PROs: Giving Credence to the Patientās Perspective in Healthcare Decision Making Authors: van Engen A, New M, Beatrice Bƶhler Y, Holmstrom S, Boerlum Kristensen F Journal: ISPOR Value & Outcomes Spotlight Year: 2020 Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award